Skip to content

AOCI at other companies

Eli Lilly logo
Eli LillyLLY
-$2.83B+24.9%
Pfizer logo
PfizerPFE
-$7.2B+16.1%
Summit Therapeutics logo
Summit TherapeuticsSMMT
-$2.63M-2.7%
Incyte logo
IncyteINCY
$22.31M+458%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$31.02M-7.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$8K

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's AOCI?
Exelixis (EXEL) reported AOCI of -$415K in Q1 2026.
How has Exelixis's AOCI changed year-over-year?
Exelixis's AOCI decreased by 120.6% year-over-year, from $2.01M to -$415K.
What is the long-term trend for Exelixis's AOCI?
Over 5 years (2020 to 2025), Exelixis's AOCI has grown at a -4.9% compound annual growth rate (CAGR), from $4.48M to $3.48M.
What does AOCI mean?
The cumulative total of unrealized gains and losses not yet reflected in net income.
How do you interpret AOCI?
Fluctuations often reflect macroeconomic factors like interest rate changes or currency volatility rather than operational performance.
How does AOCI compare across companies?
Varies significantly based on the company's exposure to international markets and investment portfolio composition.